News

new

The Delta-S family of systems

DVD 5.0 - EVG - ETV - ST5

The Delta-S family of systems is a direct offshoot of the basic research of Delta R&D, the sole proprietor of the method, and has no equivalent either in advanced research or in the theoretical tenets characterizing it, including the technological developments present on the national and foreign market. The systems are not for sale, but entrusted to companies that, by means of affiliation, agree to accept rigorous controls imposed on the service rendered and are willing to collaborate with public structures in the dissemination of the methods developed.

For the purpose of protecting intellectual property and industrial secrecy, we have never published details of the theoretical and technological principles required for the construction and development of the Systems by third parties, nor can they be purchased, but only granted in exclusive licence to the affiliated centres. Should third parties not associated with us declare that they can provide similar systems, as regards both technology and principle of functioning, they are actually engaged in defrauding the user by their illegal exploitation of our image and the clinical trials performed.

The aim of the informative topics presented in this section is to simplify and clarify as far as possible for the user every aspect of substantial importance for the successful outcome of the treatment he or she is undergoing. The main feature of the entire Delta-S Systems family is to function correctly only within the bounds of rigorous protocol parameters, which often demand the modification of other concomitant therapies. For this reason it is important to warn any physicians to whom you might approach to seek solutions to problems other than those related to the treatment in progress and to request that, before prescribing any treatment, they should contact the medical staff of the centre where you are receiving treatment in order to ensure coordination and the detection of any incompatibility. It is also necessary to avoid the self-prescription of medication, even of off the shelf medicines or those deemed “harmless” such as herbs, homeopathy, vitamins, etc. Straying from these guidelines can diminish or cancel out the results obtained. More often they entail a significant prolongation of treatment time with a reduction of the favourable changes that could be expected under optimal application conditions.

Special care must be taken in the case of diabetic patients. In most cases, during the course of treatment, a dynamic reduction in insulin dosage will be required as the existing dosage could prove excessive owing to the effect of the treatment. The procedure for modifying the dosage must be negotiated with the treating physician after thorough monitoring of the blood sugar parameters, and not autonomously.

During treatment using the EVG and DVD systems, if you happen to suffer from hypertension, in the vast majority of cases your blood pressure will tend to normalize. If you are taking prophylactic medication for this purpose, you should inform your treating physician who can then adjust the dosage in the course of the treatment. A relatively long treatment cycle may demand complete weaning off the prophylaxis. You should also remember that these drugs should never be interrupted abruptly or autonomously. At the end of treatment, even if your blood pressure has normalized in the absence of any other treatment, take the precaution of having it checked frequently to guard against any relapses.

Treatment with antibiotics may be prescribed only in cases of true necessity. During the intake of these drugs, treatment must be suspended in order to avoid any adverse interactions. It is a good rule to undergo short periods of treatment (not exceeding one week), selecting the appropriate drugs and the correct dosages. If an antibiotic is used preventively in the case of viral infection and you are undergoing treatment using the DVD or EVG system, this treatment generally becomes much more effective owing to its high efficiency in favourably modulating the immune response. In such a case, the feverish symptoms may be more pronounced (greater effectiveness in attacking the infection) but of shorter duration and may easily be treated with antipyretics.

The use of antiaggregants is compatible with treatment. To avoid having to modify the dosage is is sufficient to take the tablets at least four hours prior to therapy or, preferably, at the end thereof. This precaution is generally valid for all other kinds of medication not mentioned herein.